11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

#o

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/29/24 17:00
11/27/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo Diagnostic33S.d-145274.960-12D
11/22/24 18:16
9/30/24
AWHAspira Women'S Health Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic67M.d00.0004011398D
11/21/24 18:30
11/19/24
ORKAOruka Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11M.d00.00016053,372I
11/19/24 16:39
11/15/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic33S-1,97383.980-23811D
11/12/24 08:01
11/11/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11P30826.820124040D
10/29/24 14:06
10/28/24
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo Diagnostic1228M.d2,71714.35018960504D
10/11/24 17:23
9/11/24
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo Diagnostic45S-2,35626.740-881,250D
10/9/24 13:18
9/6/24
NUTXCardio Diagnostics Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic37P.a1300.28970448143,565D
10/4/24 19:40
10/2/24
OCXOncocyte CorpCAHealthDiagnIn Vitro & In Vivo Diagnostic22P.d3,9782.9501,3491212,523D
10/4/24 17:29
10/2/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11S-3819.010-247D
9/4/24 21:13
2/2/24
IONSIonis Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo Diagnostic11S.a-10749.540-293D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact